ETFChannel.com
DHR Description — Danaher Corp

Danaher designs, manufactures and markets medical, industrial and commercial products and services. Co.'s segments are: Life Sciences, which provides instruments to study genes, proteins, metabolites and cells, in order to understand the causes of disease, identify therapies, and test drugs and vaccines; Diagnostics, which provides clinical instruments, reagents, consumables, software and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions; and Environmental and Applied Solutions, which provides products and services that help protect resources and keep global food and water supplies safe.

Company Name: 
Danaher Corp
Website: 
www.danaher.com
Sector: 
Biotechnology
Number of ETFs Holding DHR: 
110
Total Market Value Held by ETFs: 
$21,385,547,684.75
Total Market Capitalization: 
$216,248,000,000
% of Market Cap. Held by ETFs: 
9.89%
 ETF   DHR Weight   DHR Amount 
 VTI   0.45%   $5,691,959,784         
 VOO   0.53%   $4,243,252,948         
 SPY   0.52%   $2,052,137,016         
 IVV   0.53%   $1,682,808,214         
 XLV   3.82%   $1,521,603,283         
 VTV   0.55%   $834,349,783         
 VUG   0.49%   $782,477,625         
 VHT   3.44%   $674,718,552         
 IWD   0.91%   $501,800,781         
 USMV   1.23%   $361,034,557         
List of all 110 ETFs holding DHR »
Quotes delayed 20 minutes

Email EnvelopeFree DHR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (3.62 out of 4)
57th percentile
(ranked higher than approx. 57% of all stocks covered)

Analysts Forecast:
DHR Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding DHR | Danaher Corp | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.